Clinical implications of neuroendocrine differentiation in prostate cancer

被引：71
|
作者：
Nelson, E. C. [1 ]
Cambio, A. J. [1 ]
Yang, J. C. [1 ]
Ok, J-H [1 ]
Lara, P. N., Jr. [1 ]
Evans, C. P. [1 ]
机构：
[1] Univ Calif Davis, Med Ctr, Dept Urol, Sacramento, CA 95817 USA
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2007年 / 10卷 / 01期
关键词：
androgen-independent prostate cancer; hormone refractory; neuroendocrine cells; neuroendocrine differentiation;
D O I：
10.1038/sj.pcan.4500922
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The cellular signaling pathways of the prostate play a central role in the induction, maintenance, and progression of prostate cancer (CaP). Neuroendocrine ( NE) cells demonstrate attributes that suggest they are an integral part of these signaling cascades. We summarize what is known regarding NE cells in CaP focusing on NE cellular transdifferentiation. This significant event in CaP progression appears to be accelerated by androgen deprivation ( AD) treatment. We examine biochemical pathways that may impact NE differentiation in a chronological manner focusing on AD therapy ( ADT) as a central event in inducing androgen-independent CaP. Our analysis is limited to the common adenocarcinoma pattern of CaP and excludes small-cell and carcinoid prostatic variants. In conclusion, we speculate on the future of treatment and research in this area.
引用
收藏
页码：6 / 14
页数：9
相关论文
共 50 条
  • [1] Clinical implications of neuroendocrine differentiation in prostate cancer
    E C Nelson
    A J Cambio
    J C Yang
    J-H Ok
    P N Lara
    C P Evans
    Prostate Cancer and Prostatic Diseases, 2007, 10 : 6 - 14
  • [2] Clinical investigation of neuroendocrine differentiation in prostate cancer
    Shimomura, Tatsuya
    Kurauchi, Takashi
    Sakanaka, Keigo
    Kimura, Takahiro
    Egawa, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [3] Neuroendocrine differentiation of prostate cancer and clinical outcome of Everolimus against neuroendocrine prostate cancer (NEPC)
    Shimomura, Tatsuya
    Kurauti, Takashi
    Sakanaka, Keigo
    Suzuki, Hidenori
    Goto, Hirokazu
    Endo, Yasuhiko
    Egawa, Shin
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 359 - 359
  • [4] Neuroendocrine differentiation in prostate cancer: Implications for new treatment modalities
    Vashchenko, N
    Abrahamsson, PA
    EUROPEAN UROLOGY, 2005, 47 (02) : 147 - 155
  • [5] Neuroendocrine differentiation in prostate cancer
    Jiaoti Huang Department of Pathology
    The Journal of Biomedical Research, 2008, (02) : 106 - 106
  • [6] Neuroendocrine differentiation in prostate cancer
    Sun, Yin
    Niu, Junyang
    Huang, Jiaoti
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2009, 1 (02): : 148 - 162
  • [7] Prostate cancer and neuroendocrine differentiation
    Tan M.Ö.
    Karaoǧlan Ü.
    Çelik B.
    Ataoǧlu Ö.
    Biri H.
    Bozkirli I.
    International Urology and Nephrology, 1999, 31 (1) : 75 - 82
  • [8] Neuroendocrine differentiation of prostate cancer
    Li, Zhen
    Chen, Clark J.
    Wang, Jason K.
    Hsia, Elaine
    Li, Wei
    Squires, Jill
    Sun, Yin
    Huang, Jiaoti
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (03) : 328 - 332
  • [9] Neuroendocrine differentiation in prostate cancer
    Shariff, Amir H.
    Ather, M. Hammad
    UROLOGY, 2006, 68 (01) : 2 - 8
  • [10] Neuroendocrine differentiation in prostate cancer
    Huang, J
    Wu, C
    Yao, J
    di Sant'Agnese, PA
    IAP 2005: Proceedings of the 4th Asia-Pacific International Academy of Pathology Congress, 2005, : 57 - 61
12345